Teva to provide two generic inhaler products to Direct Relief for its network of free and charitable clinicsThe program, ...
In late 2023, Teva filed a complaint for patent infringement in response to Amneal’s ANDA filing seeking to make and sell a generic version of ProAir HFA (albuterol sulfate) Inhalation Aerosol ...